Reference number: 2025-0332
The German Cancer Research Center (DKFZ) is one of Europe's largest cancer research centers. “Research for a life without cancer" is the mission of our world-class scientists and all our team members.
The DKFZ is a place where the brightest minds pursue bold ideas and seek answers to pioneering scientific questions through collaboration, innovation, and exploration across many disciplines. We provide a dynamic environment which empowers excellence with state-of-the-art technologies, cutting edge infrastructure, and a global scientific network.
Contribute your knowledge, vision, and dedication to create a space where scientific discovery in cancer research is transformed into benefits for human health.
The Hopp Children's Cancer Center Heidelberg (KiTZ) is a joint institution of the DKFZ, Heidelberg University Hospital (UKHD), and the University of Heidelberg (UniHD). As a treatment and research center for oncological and hematological diseases in children and adolescents, KiTZ is committed to exploring the biology of childhood cancer and closely linking promising research approaches with patient care – from diagnosis to treatment and aftercare.
The Clinical Cooperation Unit "Pediatric Oncology" and the Division of Pediatric Neurooncology at the German Cancer Research Center and the Hopp Children's Cancer Center Heidelberg are jointly seeking a
Drug Sensitivity Profiling & Multi-Omics Integration Clinical drug sensitivity profiling and identification of novel biomarkers in both patient-derived and cell line datasets. Responsibilities include large-scale integration of multi-omics and drug sensitivity data, development and maintenance of cohort-based drug response classification applications, and scripting for automated drug screening workflows. The ultimate goal is to identify novel therapeutic targets and improve diagnosis, prevention, and treatment outcomes in pediatric oncology
The project also involves exploration of high-content imaging datasets; Therefore, experience or interest in AI-based image analysis would be advantageous.
The position is jointly hosted by the groups “Translational Genomics” led by Dr. Robert J. Autry and “Functional Pediatric Precision Oncology” led by Prof. Dr. Ina Oehme.
Genomic and functional screening approaches include, but are not limited to:
Whole-genome sequencing, RNA-seq, ChIP-seq, single-cell and spatial transcriptomics, and large-scale drug response assays ; imaging approaches include multiplex confocal microscopy and live cell imaging
Interested candidates should submit the following documents via our online application tool:
Then become part of the DKFZ and join us in contributing to a life without cancer!
Elisabeth Hillier
Phone: +49 (0)6221/42-3272
We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.
More than 450,000 people are diagnosed with cancer each year in Germany. Cancer is a disease that poses enormous challenges to research, because every cancer is different and its course can vary immensely even from one patient to the next. To perform research into cancer is the task of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) according to its statutes. DKFZ is the largest biomedical research institute in Germany and a member of the Helmholtz Association of National Research Centers. In over 90 divisions and research groups, our more than 3,000 employees, of which more than 1,200 are scientists, are investigating the mechanisms of cancer, are identifying cancer risk factors and are trying to find strategies to prevent people from getting cancer.They are developing novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful.